Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("AZATHIOPRINE")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 2766

  • Page / 111
Export

Selection :

  • and

Azathioprine in dermatology : The past, the present, and the futurePATEL, Akash A; SWERLICK, Robert A; MCCALL, Calvin O et al.Journal of the American Academy of Dermatology. 2006, Vol 55, Num 3, pp 369-389, issn 0190-9622, 21 p.Article

Azathioprine-induced shock in a patient suffering from undifferentiated erosive oligoarthritisDEMIRTAS-ERTAN, G; ROWSHANI, A. T; TEN BERGE, I. J. M et al.Netherlands journal of medicine. 2006, Vol 64, Num 4, pp 124-126, issn 0300-2977, 3 p.Article

Azathioprine and breastfeeding- : is it safe?SAU, A; DARKE, S; BASS, J et al.BJOG (Oxford. Print). 2007, Vol 114, Num 4, pp 498-501, issn 1470-0328, 4 p.Article

FIELD DESORPTION MASS SPECTROMETRY OF AZATHIOPRINE AND ITS METABOLITES = LA SPECTROMETRIE DE MASSE AVEC DESORPTION DU CHAMP DE L'AZATHIOPRINE ET DE SES METABOLITESBRENT DA; DE MIRANDA P; SCHULTEN HR et al.1974; J. PHARM. SCI.; U.S.A.; DA. 1974; VOL. 63; NO 9; PP. 1370-1375; BIBL. 15 REF.Article

Off-label Use of Azathioprine in Dermatology: A Systematic ReviewSCHRAM, Mandy E; BORGONJEN, Rinke J; BIK, Cathelijne M. J. M et al.Archives of dermatology (1960). 2011, Vol 147, Num 4, pp 474-488, issn 0003-987X, 15 p.Article

Remission with ursodeoxycholic acid of type 1 autoimmune hepatitis resistant to azathioprine and steroidsDUCLOS-VALLEE, Jean-Charles; DI MARTINO, Vincent; CAZIER, Alain et al.Gastroentérologie clinique et biologique. 2005, Vol 29, Num 11, pp 1173-1176, issn 0399-8320, 4 p.Article

Azathioprine dose escalation in inflammatory bowel diseaseRAYNER, C. K; HART, A. L; HAYWARD, C. M. M et al.Alimentary pharmacology & therapeutics. 2004, Vol 20, Num 1, pp 65-71, issn 0269-2813, 7 p.Article

Azathioprine prescribing in neurologyGOLDSMITH, Paul; LENNOX, Graham; BHALLA, Narinder et al.Journal of neurology. 2008, Vol 255, Num 6, pp 791-795, issn 0340-5354, 5 p.Article

AUTOIMMUNE HEMOLYTIC ANEMIA AND CYTOMEGALOVIRUS INFECTION IN A SIX MONTHS OLD CHILD, TREATED WITH AZATHIOPRINE = UNE ANEMIE HEMOLYTIQUE AUTOIMMUNE ET UNE INFECTION A VIRUS CYTOMEGALIQUE CHEZ UN ENFANT DE 6 MOIS TRAITE PAR DE L'AZATHIOPRINEBOSSI E; WAGNER HP.1972; HELV. PAEDIATR. ACTA; SUISSE; DA. 1972; VOL. 27; NO 2; PP. 155-162; ABS. ALLEM.; BIBL. 1P.Serial Issue

British Association of Dermatologists' guidelines for the safe and effective prescribing of azathioprine 2011MEGGITT, S. J; ANSTEY, A. V; MOHD MUSTAPA, M. F et al.British journal of dermatology (1951). 2011, Vol 165, Num 4, pp 711-734, issn 0007-0963, 24 p.Article

Métabolisme de l'azathioprine : que faut-il faire ou ne pas faire en pratique clinique ? = Azathioprine metabolism : What to do or not to do in clinical practice?ROBLIN, X; OUSSALAH, A; PHELIP, J.-M et al.Gastroentérologie clinique et biologique. 2009, Vol 33, Num 3, pp 172-175, issn 0399-8320, 4 p.Article

Azathioprine use during pregnancy : Unexpected intrauterine exposure to metabolitesDE BOER, Nanne K. H; JARBANDHAN, Soeresh V. A; DE GRAAF, Peer et al.The American journal of gastroenterology. 2006, Vol 101, Num 6, pp 1390-1392, issn 0002-9270, 3 p.Article

Azathioprine formulation optimizes metabolite profile in inflammatory bowel diseaseSTEVENS, T; ACHKAR, J. P; EASLEY, K et al.Alimentary pharmacology & therapeutics. 2004, Vol 20, Num 6, pp 601-606, issn 0269-2813, 6 p.Article

Difficult treatment issues in sarcoidosisBAUGHMAN, R. P; LYNCH, J. P.Journal of internal medicine. 2003, Vol 253, Num 1, pp 41-45, issn 0954-6820, 5 p.Conference Paper

Breast-feeding during maternal use of azathioprineMORETTI, Myla E; VERJEE, Zul; ITO, Shinya et al.The Annals of pharmacotherapy. 2006, Vol 40, Num 12, pp 2269-2272, issn 1060-0280, 4 p.Article

Development of Beau's lines in two patients receiving azathioprineMAKHZOUMI, Zaineb; DECAPITE, Timothy; GASPARI, Anthony et al.Journal of dermatological treatment. 2009, Vol 20, Num 4, pp 246-247, issn 0954-6634, 2 p.Article

Two cases of distinctive exudative discoid and lichenoid chronic dermatosis of Sulzberger and Garbe responding to azathioprineFREEMAN, K; HEWITT, M; WARIN, A. P et al.British journal of dermatology (1951). 1984, Vol 111, Num 2, pp 215-220, issn 0007-0963Article

CHEMICAL IMMUNOSUPPRESSIONSALAMAN JR.1981; ANN. CLIN. RES.; ISSN 0003-4762; FIN; DA. 1981; VOL. 13; NO 4-5; PP. 307-312; BIBL. 44 REF.Article

THE EFFECT OF AZATHIOPRINE (IMURAN) ON THE KINETICS OF MONOCYTES AND MACROPHAGES DURING THE NORMAL STEADY STATE AND AN ACUTE INFLAMMATORY REACTION. = EFFET DE L'AZATHIOPRINE (IMURAN) SUR LA CINETIQUE DES MONOCYTES ET DES MACROPHAGES AU COURS DE L'ETAT STATIONNAIRE NORMAL ET D'UNE REACTION INFLAMMATOIRE AIGUEGASSMANN AE; VAN FURTH R.1975; BLOOD; U.S.A.; DA. 1975; VOL. 46; NO 1; PP. 51-64; BIBL. 25 REF.Article

A CONTROLLED TRIAL OF AZATHIOPRINE IN CROHN'S DISEASE.ROSENBERG JL; LEVIN B; WALL AJ et al.1975; AMER. J. DIGEST. DIS.; U.S.A.; DA. 1975; VOL. 20; NO 8; PP. 721-726; BIBL. 13 REF.Article

SIDEROBLASTIC ANEMIA TREATED WITH IMMUNOSUPPRESSIVE THERAPYZERVAS J; GEARY CG; OLEESKY S et al.1974; BLOOD; U.S.A.; DA. 1974; VOL. 44; NO 1; PP. 117-123; BIBL. 18REF.Article

IMMUNOSUPPRESSIVE AND ANTIINFLAMMATORY PROPERTIES OF CYCLOPHOSPHAMIDE, AZATHIOPRINE AND METHOTREXATEHURD ER.1973; ARTHRIT. AND RHEUMATISM; U.S.A.; DA. 1973; VOL. 16; NO 1; PP. 84-88; BIBL. 22REF.Serial Issue

THE EFFECT OF AZATHIOPRINE ON GASTRIC MUCOSAL HISTOLOGY AND ACID SECRETION IN CHRONIC GASTRITISJORGE AD; SANCHEZ D.1973; ; GUT; G.B.; DA. 1973; VOL. 14; NO 2; PP. 104-106; BIBL. 13REF.Serial Issue

AZATHIOPRINE TREATMENT IN ACTIVE CHRONIC HEPATITIS. EVALUATION OF DOSE LEVELSGJONE E; BOYE NP; BLOMHOFF JP et al.1973; ACTA MED. SCAND.; SUEDE; DA. 1973; VOL. 193; NO 1-2; PP. 109-112; BIBL. 10 REF.Serial Issue

CLINICAL, BIOCHEMICAL, AND HISTOLOGICAL REMISSION OF SEVERE CHRONIC ACTIVE LIVER DISEASE: A CONTROLLED STUDY OF TREATMENTS AND EARLY PROGNOSIS = REMISSION CLINIQUE, BIOCHIMIQUE ET HISTOLOGIQUE D'AFFECTION HEPATIQUE CHRONIQUE ACTIVE SEVERE: ETUDE CONTROLEE DES TRAITEMENTS ET PRONOSTIC PRECOCESOLOWAY RD; SUMMERSKILL WHJ; BAGGENSTOSS AH et al.1972; GASTROENTEROLOGY; U.S.A.; DA. 1972; VOL. 63; NO 5; PP. 820-833; BIBL. 34REF.Serial Issue

  • Page / 111